The Infectious Diseases division enjoys a national and international reputation for excellence. Led by Terence Dermody, M.D., the division includes investigative leaders in numerous research areas, award-winning teachers, and highly skilled physicians. Kathryn Edwards, M.D., was recently elected to the Institute of Medicine (IOM) of the National Academies, and also became a member of the Board of Directors for the National Foundation of Infectious Diseases. Division members have been recognized with major awards and honors for their research. Most recently, Mark Denison, M.D., was named a Fellow of the American Association for the Advancement of Science, C. Buddy Creech, M.D., MPH, received the Young Investigator Award from the Pediatric Infectious Diseases Society and James E. Crowe, Jr, M.D., received the Mentor of the Year Award from the Vanderbilt Postdoctoral Association.
The Institute for Global Health, directed by Sten Vermund, M.D., Ph.D., the Program in Vaccine Sciences, directed by Crowe, and the Vanderbilt Vaccine Research Program, directed by Edwards, are closely affiliated with the division. Directors and several faculty members in these groups have primary or affiliate appointments in the division and collaborate extensively with divisional faculty in research, training, and patient care.
Research has been at the forefront of professional activities in the division since its establishment in 1974. The division enjoys investigative strengths in microbial pathogenesis, human immunology, vaccine science, and public health. The diversity of research interests is impressive in scope, spanning studies of single molecules to diverse populations across the world. Large, multi-investigator programs affiliated with the division include the Southeast Regional Center of Excellence for Emerging Infections and Biodefense,led by Mark Denison, M.D., the Vanderbilt Vaccine and Treatment Evaluation Unit, led by Edwards, and the Fogarty Global Health Fellowships representing Vanderbilt University, Emory University, Cornell University and Duke University.
Training is a core component of our mission. Research program receive funding from organizations such as the National Institutes of Health, national and international private industries, and private foundations. Ongoing research efforts include respiratory syncytial virus (RSV), influenza virus, parainfluenza, S. aureus molecular epidemiology and pathogenesis, tuberculosis, vaccine combinations, and HIV vaccines. Mucosal immunity, pathogenesis of RSV disease, HIV assembly, and developmental B-cell immunity are special areas of interest.
Last Edited: October 10, 2012